Cambridge Investment Research Advisors, Inc. Statera Biopharma, Inc. Transaction History

Cambridge Investment Research Advisors, Inc.

  • $29.9 Billion
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$0.08 - $0.23 $720 - $2,070
-9,000 Reduced 13.08%
59,825 $5,000
Q2 2022

Jul 13, 2022
SELL
$0.21 - $0.38 $298 - $539
-1,421 Reduced 2.02%
68,825 $19,000
Q1 2022

May 12, 2022
BUY
$0.31 - $2.27 $3,165 - $23,178
10,211 Added 17.01%
70,246 $22,000
Q4 2021

Feb 03, 2022
SELL
$2.01 - $4.08 $24,099 - $48,919
-11,990 Reduced 16.65%
60,035 $138,000
Q3 2021

Nov 02, 2021
BUY
$2.29 - $6.24 $164,937 - $449,436
72,025 New
72,025 $166,000

Others Institutions Holding STAB

# of Institutions
4
Shares Held
30K
Call Options Held
0
Put Options Held
0
View Full List

About Statera Biopharma, Inc.

STAB Quotes by TradingView
  • Ticker STAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,295,700
  • Description
  • Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within ...
More about STAB
Track This Portfolio

Track Cambridge Investment Research Advisors, Inc. Portfolio

Follow Cambridge Investment Research Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email